Literature DB >> 27033129

Therapy: Metformin protective against colorectal cancer?

Charlotte Ridler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27033129     DOI： 10.1038/nrgastro.2016.61

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.

Authors:  Takuma Higurashi; Kunihiro Hosono; Hirokazu Takahashi; Yasuhiko Komiya; Shotaro Umezawa; Eiji Sakai; Takashi Uchiyama; Leo Taniguchi; Yasuo Hata; Shiori Uchiyama; Akiko Hattori; Hajime Nagase; Takaomi Kessoku; Jun Arimoto; Nobuyuki Matsuhashi; Yoshiaki Inayama; Shoji Yamanaka; Masataka Taguri; Atsushi Nakajima
Journal:  Lancet Oncol       Date:  2016-03-03       Impact factor: 41.316
  1 in total
  1 in total

1.  Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo.

Authors:  Yanmin Wang; Yanli Meng; Shijun Zhang; Huancheng Wu; Dawei Yang; Chaohui Nie; Qunliang Hu
Journal:  Onco Targets Ther       Date:  2018-09-20       Impact factor: 4.147
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.